SLXN
NASDAQ · Biotechnology
Silexion Therapeutics Corp
$1.20
-0.02 (-1.64%)
Open$1.23
Previous Close$1.22
Day High$1.29
Day Low$1.19
52W High$22.36
52W Low$1.07
Volume—
Avg Volume51.5K
Market Cap4.36M
P/E Ratio—
EPS$-12.44
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+2,920.0% upside
Current
$1.20
$1.20
Target
$36.24
$36.24
$26.81
$36.24 avg
$52.45
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.24M | 2.11M | 2.20M |
| Net Income | -331,103 | -245,653 | -236,110 |
| Profit Margin | -14.8% | -11.6% | -10.7% |
| EBITDA | -455,957 | -486,512 | -478,296 |
| Free Cash Flow | -187,144 | -193,211 | -204,399 |
| Rev Growth | -3.1% | +9.8% | -1.4% |
| Debt/Equity | 0.51 | 0.41 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |